Earnings lift markets to higher close

Upbeat earnings lifted the markets to a higher close with Dow gaining 21 points to 18,080. Nasdaq climbed 36 points to 5,092.

On the upside

The Lancelot published positive results from a Phase 3 study of GlaxoSmithKline's (NYSE: GSK) malaria vaccine RTS,S, which incorporates Agenus' (NYSE: AGEN) QS021 Stimulon.

Shares of Vale (NYSE: VALE) climbed after rival iron ore producer BHP Billiton (NYSE: BHP) announced plans to scale down its expansion plans.

Third quarter earnings slipped for Microsoft (Nasdaq: MSFT) but the results topped analyst estimates prompting an upgrade.

On the downside

Catalyst Pharmaceutical's (Nasdaq: CPRX) rival Jacobus Pharmaceuticals presented positive data for a drug that is similar to one being developed by Catalyst.

DeVry Education Group (NYSE: DV) reported lower third quarter earnings and revenue.

ResMed (NYSE: RMD) reported higher quarter earnings and revenue but Macquarie downgraded the company from an Outperform rating to a Neutral rating.
In the broad market, advancing issues barely edged out decliners by a slim margin on the NYSE while decliners outpaced advancers by nearly 5 to 4 on Nasdaq. The broader S&P 500 added 4 points to 2117. Bitcoin edged up $1 to $230.

About this Entry

This page contains a single entry by published on April 24, 2015 3:44 PM.

Markets higher on strong earnings was the previous entry in this blog.

Markets open higher as oil rises is the next entry in this blog.

Find recent content on the main index or look in the archives to find all content.

Powered by Movable Type 5.12